Untitled
Lung 20icon

Respiratory Motion, Inc. (RMI)

RMI's ExSpiron is an "EKG for the Lung" - the first non-invasive respiration monitor providing an early warning to help prevent and treat respiratory failure

  • Stage $3M in TTM Revenue
  • Industry Medical Devices and Equipment
  • Location Watertown, MA, USA
  • Currency USD
  • Founded March 2010
  • Employees 25
  • Incorporation Type C-corp
  • Website respiratorymotion.com

Company Summary

Respiratory Motion Inc. has developed and commercialized the first and only FDA cleared respiratory monitor, the ExSpiron®, that is able to alert caregivers about deteriorating respiration in advance of adverse events, in advance of other methods and in time to make a difference. Acting as an “EKG for the Lungs” the ExSpiron increases patient safety while decreasing hospital costs and is becoming the standard of care for respiratory monitoring.

Team

  • Default avatar
    Jenny Freeman
    President and CEO

    30 years in Cardiothoracic Surgery and medical device entrepreneurship, bringing products from concept to market. She authored >70 articles, NIH grants and multiple patents. BA Yale; MD and Surgery Residency NYU (UCSF, Boston Children’s Hospital); Postdoc Fellow UW; Cardiothoracic Fellow UAB; Pediatric Cardiovascular Fellow CHOP. She developed and ran several surgical practices, several medical device companies and a Wall Street research firm.

  • Default avatar
    Alexander Panasyuk
    CTO

    25 years leading engineering teams. Long expertise in medical device development and commercialization, from concept through FDA clearance and into the marketplace. Previous experience at Harvard Smithsonian Astrophysics. Moscow Institute of Physics & Technology (PhD). He is an author of multiple publications and is on all of Respiratory Motion's patent applications.

  • Default avatar
    Peter Aranow
    CFO

    40 yrs finance experience; multiple positions in investment banking at Bear Stearn, including CFO and Managing DIrector, CFO of multiple public and private companies, expertise in corporate governance
    BS & MBA at Harvard

  • Default avatar
    Svetlana Panasyuk
    VP of Software and Algorithms

    22 years of experience managing teams of engineers in research & data analysis in medical product companies, Massachusetts Institute of Technology, PhD Geophysics, previous experience included senior positions at Mathworks and Lincoln Laboratories

  • Default avatar
    Kevin Hughes
    VP Operations

    Extensive experience in MIS, HR, finance and operations
    MBA at University of Rhode Island

  • Default avatar
    Paul Heller
    VP Manufacturing

    20+ yrs manufacturing and operations (Waters, Lasertron, M Cubed)
    MBA, University of Rochester / Wharton Ops Management Program

  • Default avatar
    Michele Blair
    National Sales Director

    12 years business finance industry, Ernst and Young
    16 years medical device sales (Haemonetics, Ethicon)
    BS, Business Administration and Finance, Indiana U, CPA

Advisors

  • Default avatar
    Anne DeGheest
    Unconfirmed
    Default avatar
    james remenick
    Unconfirmed

Previous Investors

  • Default avatar
    Cherrystone, Golden Seeds, Walnut, Boston Harbor, Boynton, eCoast, Angel Investment Forum, Maine
    Unconfirmed
    Default avatar
    Ariel Savanah Angels, Beta Fund, Central Illinois Angels, Jenny Freeman, Jean Hammond
    Unconfirmed
    Default avatar
    Grants: Qualifying Therapeutic Discovery Project, Mass Life Science Intern Program
    Unconfirmed
  • Default avatar
    Tom Feller
    Unconfirmed
  • Default avatar
    Grant: FDA - Pediatric device development with Children's Hospital of Boston
    Unconfirmed